ARETAEUS

Alzheimer disease, a new indication for diabetes drugs? After the intensive and successful research that leads to new indications for diabetes drugs as SGLT-2s and GLP-1s in cardio-vascular and kidney diseases in patients with and without diabetes, we start to see a revival of the interest of diabetes drugs for neurological diseases as Alzheimer or …... Q3 2020 Reporting Here is the new report on diabetes R&D news. As for each quarter, I propose a report on the different R&D, business, and regulatory news in diabetes and some related diseases (Obesity, NASH…). This report is free of charges for HCPs, academics, patients, and for-non-profit organizations. This quarter report includes a few …

Primary location: Columbus United States